These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 36701332

  • 1. Patient-Controlled Analgesia vs Intravenous Push Hydromorphone for Pain Management of Vaso-Occlusive Crisis Associated With Sickle Cell Disease.
    Russo K, Chhunchha P.
    J Pain Palliat Care Pharmacother; 2023 Jun; 37(2):116-122. PubMed ID: 36701332
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP, Twilla JD, Kemp L, Phelps GL, Reaves A.
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [Abstract] [Full Text] [Related]

  • 3. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
    van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ.
    Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
    [Abstract] [Full Text] [Related]

  • 4. A Comparison of Two Regimens for Managing Sickle Cell Pain and Reducing Readmissions.
    Cheng E, Floroff C, Ingemi AI, Vasist N, Ko A, Goodman BM.
    J Pain Palliat Care Pharmacother; 2021 Sep; 35(3):143-149. PubMed ID: 34254882
    [Abstract] [Full Text] [Related]

  • 5. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
    Allen Liles E, Kirsch J, Gilchrist M, Adem M.
    Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
    [Abstract] [Full Text] [Related]

  • 6. Patient-controlled Analgesia For Vaso-Occlusive Crisis: A Cohort Study.
    Averbukh Y, Porrovecchio A, Southern WN.
    Clin J Pain; 2019 Aug; 35(8):686-690. PubMed ID: 31136312
    [Abstract] [Full Text] [Related]

  • 7. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis.
    Assad O, Zamora R, Brown K, Melnitsky L, Moses J, Sherman V.
    Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of Vaso-occlusive Crisis Management With Patient-Controlled Analgesia in Children With Sickle Cell Disease Requiring Hospitalization.
    Arbitre C, Pastore Y, Bailey B, Kleiber N, Robitaille N, Villeneuve E, Viau A, Bergeron MJ, Trottier ED.
    J Pediatr Pharmacol Ther; 2021 Feb; 26(6):615-623. PubMed ID: 34421412
    [Abstract] [Full Text] [Related]

  • 9. A comparison of two regimens of patient-controlled analgesia for children with sickle cell disease.
    Trentadue NO, Kachoyeanos MK, Lea G.
    J Pediatr Nurs; 1998 Feb; 13(1):15-9. PubMed ID: 9503762
    [Abstract] [Full Text] [Related]

  • 10. A multimodal pain protocol for treatment of vaso-occlusive crisis in patients with sickle cell disease: Implementation and evaluation.
    Admiraal M, van Daalen J, Ritt MWJ, Dekker J, van Tuijn CFJ, Nur E, Hollmann MW, Hermanns H, Hermanides J, Biemond BJ.
    Eur J Haematol; 2023 Sep; 111(3):382-390. PubMed ID: 37277324
    [Abstract] [Full Text] [Related]

  • 11. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA, DeSilva MS, Munube D, Nkwine R, Tumukunde J, Agaba PK, Nabukenya MT, Bulamba F, Luggya TS.
    Scand J Pain; 2018 Jan 26; 18(1):19-27. PubMed ID: 29794277
    [Abstract] [Full Text] [Related]

  • 12. Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department.
    Gonzalez ER, Bahal N, Hansen LA, Ware D, Bull DS, Ornato JP, Lehman ME.
    Arch Intern Med; 1991 Jul 26; 151(7):1373-8. PubMed ID: 2064488
    [Abstract] [Full Text] [Related]

  • 13. Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes.
    Dampier CD, Smith WR, Kim HY, Wager CG, Bell MC, Minniti CP, Keefer J, Hsu L, Krishnamurti L, Mack AK, McClish D, McKinlay SM, Miller ST, Osunkwo I, Seaman P, Telen MJ, Weiner DL, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).
    Am J Hematol; 2011 Dec 26; 86(12):E70-3. PubMed ID: 21953763
    [Abstract] [Full Text] [Related]

  • 14. Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study.
    Rollé A, Vidal E, Laguette P, Garnier Y, Delta D, Martino F, Portecop P, Etienne-Julan M, Piednoir P, De Jong A, Romana M, Bernit E.
    Medicina (Kaunas); 2023 Dec 18; 59(12):. PubMed ID: 38138299
    [Abstract] [Full Text] [Related]

  • 15. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID, Woodward M, Reed GW.
    Pediatr Blood Cancer; 2005 Oct 15; 45(5):716-24. PubMed ID: 15926170
    [Abstract] [Full Text] [Related]

  • 16. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
    Yaster M, Tobin JR, Billett C, Casella JF, Dover G.
    Pediatrics; 1994 Feb 15; 93(2):310-5. PubMed ID: 8121746
    [Abstract] [Full Text] [Related]

  • 17. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M, López-Sangüos C, Vázquez P, Alvárez T, Marañón R, Huerta J, Cela E.
    Hemoglobin; 2016 Nov 15; 40(6):388-391. PubMed ID: 28361592
    [Abstract] [Full Text] [Related]

  • 18. Patient Controlled Analgesia for Vaso-Occlusive Episodes in Children: A Retrospective Study.
    Donado C, Harris EM, Heeney MM, Solodiuk JC, Greco CD, Archer NM.
    J Pain Symptom Manage; 2023 May 15; 65(5):e409-e415. PubMed ID: 36641004
    [Abstract] [Full Text] [Related]

  • 19. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.
    Collins JJ, Geake J, Grier HE, Houck CS, Thaler HT, Weinstein HJ, Twum-Danso NY, Berde CB.
    J Pediatr; 1996 Nov 15; 129(5):722-8. PubMed ID: 8917240
    [Abstract] [Full Text] [Related]

  • 20. Demand-only patient-controlled analgesia for treatment of acute vaso-occlusive pain in sickle cell disease.
    Carullo V, Morrone K, Weiss M, Choi J, Gao Q, Pisharoty S, Moody K, Manwani D.
    Pediatr Blood Cancer; 2022 Aug 15; 69(8):e29665. PubMed ID: 35294090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.